These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28225927)

  • 21. [Drug therapy of hepatitis B and C].
    Färkkilä M
    Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemoptysis: Call the Gastroenterologist?
    Perry I; Patel D
    Gastroenterology; 2018 Oct; 155(4):e1-e2. PubMed ID: 29885314
    [No Abstract]   [Full Text] [Related]  

  • 23. The smoldering epidemic. The number of new cases of hepatitis C is down, but millions are chronically infected and may not know it.
    Harv Health Lett; 2010 Sep; 35(11):1-3. PubMed ID: 20939121
    [No Abstract]   [Full Text] [Related]  

  • 24. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract]   [Full Text] [Related]  

  • 25. [Kidney transplantation in patients positive for hepatitis C virus].
    Campistol JM; Esforzado N; Morales JM; Barrera JM
    Nefrologia; 2002; 22 Suppl 5():62-6. PubMed ID: 12107920
    [No Abstract]   [Full Text] [Related]  

  • 26. Grafts and hepatitis C virus: maximizing the benefit.
    Mottershead M; Neuberger J
    Liver Transpl; 2007 Jul; 13(7):947-52. PubMed ID: 17600347
    [No Abstract]   [Full Text] [Related]  

  • 27. Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
    Weiler N; Zeuzem S; Welker MW
    World J Gastroenterol; 2016 Nov; 22(41):9044-9056. PubMed ID: 27895394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiviral effect of carnitine for chronic hepatitis or liver cirrhosis patients].
    Nakanishi H; Kurosaki M; Izumi N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():121-3. PubMed ID: 26845915
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 30. The importance of IL28B genotype in hepatitis C virus-associated liver transplantation.
    Lange CM
    Liver Int; 2013 Feb; 33(2):169-71. PubMed ID: 23295049
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimal duration of pre-liver transplantation anti-hepatitis C virus treatment with direct-acting agent sofosbuvir.
    Borentain P; Colson P; Darque A; Gérolami R
    Liver Int; 2015 Jun; 35(6):1776. PubMed ID: 25619265
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of hepatitis C].
    Adler M; Thibaut P
    Rev Med Brux; 2006; 27(6):S527-8. PubMed ID: 17256423
    [No Abstract]   [Full Text] [Related]  

  • 33. EVALUATION OF ANTIVIRAL THERAPY TREATMENT FOR LIVER CIRRHOSIS CAUSED BY CHRONIC HEPATITIS C AND HEPATITIS C BY 31P-MRS, BASED ON METABOLITE DETECTION.
    Gu JS; Sun RR; Shen S; Yu ZJ
    J Biol Regul Homeost Agents; 2015; 29(2):443-50. PubMed ID: 26122235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendation for treatment of hepatitis C virus infection.
    Kaymakoğlu S; Köksal İ; Tabak F; Akarca US; Akbulut A; Akyüz F; Bodur H; Çağatay A; Dinçer D; Esen Ş; Güner R; Gürel S; Köse Ş; Şentürk Ö; Şimşek H; Yamazhan T; Yılmaz Y; Idilman R; Guidelines Study Group VH
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):94-100. PubMed ID: 29303106
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.
    O'Leary JG; McKenna GJ; Klintmalm GB; Davis GL
    Liver Transpl; 2013 Apr; 19(4):463-5. PubMed ID: 23408534
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of Hepatitis C Antibodies Without Viral Transmission in Hepatitis C-Negative Recipients Receiving Kidneys From Hepatitis C-Positive Donors Treated With Direct-Acting Antiviral Therapy.
    Agarwal N; Davis RJ; Gracey DM; Wong G; Kable K; Wong JKW; Nankivell BJ; Strasser S; Wyburn K
    Transplantation; 2018 Mar; 102(3):e121-e122. PubMed ID: 29166337
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of liver cirrhosis.
    Lancet; 2014 May; 383(9930):1694. PubMed ID: 24835601
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus infection in children in the era of direct-acting antiviral.
    Pawlowska M; Sobolewska-Pilarczyk M; Domagalski K
    World J Gastroenterol; 2018 Jun; 24(24):2555-2566. PubMed ID: 29962813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prisons, prisoners, and hepatitis C.
    Ferguson L; Batey R
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
    [No Abstract]   [Full Text] [Related]  

  • 40. Response letter: Just a matter of luck?
    Donato MF; Malinverno F; Monico S
    Liver Int; 2015 Jun; 35(6):1777. PubMed ID: 25676703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.